While cannabinoids offer a potential alternative for refractory chronic pain, optimal use requires personalized dosing and ...

The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...

Algiax Pharmaceuticals, a company committed to developing innovative treatments for chronic neuropathic pain, has released ...

Nerve Renew is a dietary supplement designed to address neurological problems and restore healthy nerve function. The formula ...

The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced ...

GRAND FORKS — A Grand Forks man is celebrating the success of a relatively new procedure for amputees, which has changed his ...

Neuropathy, a debilitating condition affecting millions worldwide, can significantly impair daily life and well-being.

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

Arialief is a comprehensive nerve health supplement that specifically targets sciatic nerve pain and claims to provide ...